Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cell Rising Capital is a venture capital firm based in Hong Kong, founded in 2020. The firm specializes in providing funding from angel to Series A stages for startups across Europe and Asia. Its mission centers on fostering cross-continental connections and facilitating the exchange of innovative technologies between these regions. This focus on early-stage technology companies positions Cell Rising Capital as a key player in the global startup funding ecosystem.
As of now, Cell Rising Capital has not disclosed its assets under management (AUM) or specific fund sizes. The firm emphasizes its commitment to supporting transformative advancements in various sectors, including advanced manufacturing, artificial intelligence (AI), biotechnology, electric vehicles (EV), financial technology (fintech), medical technology (medtech), and sustainability. The firm operates with a global perspective, particularly targeting startups that can benefit from cross-border collaboration.
Cell Rising Capital has established itself as a notable entity in the venture capital landscape, with a portfolio that includes innovative companies like Hex Trust and Wrisk. The firm’s strategic approach aims to enhance the growth potential of its portfolio companies by providing not only financial backing but also valuable insights and connections within the technology markets of Europe and Asia.
Cell Rising Capital invests in a diverse array of sectors, including advanced manufacturing, artificial intelligence (AI), biotechnology (biotech), electric vehicles (EV), financial technology (fintech), medical technology (medtech), and sustainability. The firm targets startups in the early stages of development, specifically from angel to Series A funding. This broad sector focus allows Cell Rising Capital to engage with a variety of innovative companies that are shaping the future of technology.
The firm emphasizes cross-border collaboration, seeking to connect European and Asian technology markets. This approach is particularly beneficial for startups that are looking to expand their reach and leverage opportunities in both regions. Cell Rising Capital looks for founders who demonstrate a strong vision and the ability to navigate complex technology landscapes. The firm’s investment strategy is designed to support companies that are building transformative or advanced technologies, with a keen interest in those that can facilitate international technology transfer.
While specific check sizes have not been disclosed, the firm’s focus on early-stage funding suggests that it is prepared to make significant investments to help startups achieve their growth objectives. Cell Rising Capital’s commitment to supporting innovative technologies positions it as a valuable partner for founders aiming to make an impact in their respective sectors.
Cell Rising Capital has a notable portfolio that includes several innovative companies:
These companies exemplify Cell Rising Capital's commitment to investing in sectors that are at the forefront of technological advancement. The firm’s portfolio reflects its strategy of supporting startups that are not only innovative but also have the potential for significant market impact. The focus on cross-border technology exchange is evident in the geographic diversity of its investments, spanning both Europe and Asia.
梁海燕: An employee at Cell Rising Capital, though specific details regarding their role and background have not been verified through accessible sources. The firm has not publicly disclosed a comprehensive partner roster or detailed biographies of its investment decision-makers.
As of now, the firm does not provide named General Partners or partners in its available materials. Founders should verify current decision-makers and their investment focus directly before reaching out.
To pitch Cell Rising Capital, founders should use the official email address info@cellrising.com or the contact form available on their website at cellrising.com. It is essential to include a comprehensive pitch deck that outlines the business model, market opportunity, and technology differentiation.
While specific response time expectations have not been disclosed, founders should anticipate a thorough review process. A warm introduction may enhance the chances of receiving a timely response, but it is not strictly necessary.
As of 2025, Cell Rising Capital has been active in the venture capital space, with notable portfolio companies such as Hex Trust and Wrisk. In March 2022, Hex Trust secured strategic investment from Morgan Creek, highlighting the firm's involvement in significant funding rounds.
In 2021, Wrisk raised £12 million to enhance its automotive insurance solutions, with Cell Rising Capital participating in this funding round. These activities underscore the firm's commitment to supporting innovative startups in the technology sector.
What are Cell Rising Capital's investment criteria?
Cell Rising Capital focuses on early-stage startups, specifically from angel to Series A funding. The firm invests in sectors such as advanced manufacturing, AI, biotech, EV, fintech, medtech, and sustainability. They look for companies that demonstrate transformative potential and the ability to connect European and Asian technology markets.
How can I pitch to Cell Rising Capital?
Founders can reach out to Cell Rising Capital via their official email at info@cellrising.com or through their website at cellrising.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and technology differentiation.
What makes Cell Rising Capital different from other VCs?
Cell Rising Capital emphasizes cross-continental connections between Europe and Asia, which is a unique aspect of their investment strategy. They provide not only financial support but also strategic advice and access to a network of advisors and experts to help portfolio companies navigate international markets.
What is the geographic scope of Cell Rising Capital's investments?
The firm invests globally, with a specific focus on startups in Europe and Asia. Their strategy aims to facilitate technology exchange between these regions, making them a suitable partner for companies looking to expand internationally.
What is the typical check size for investments?
While specific check sizes have not been disclosed, Cell Rising Capital focuses on early-stage funding, suggesting that they are prepared to make significant investments to support the growth of their portfolio companies.
What kind of support do portfolio companies receive?
Cell Rising Capital provides strategic advice and support through a network of advisors and experts, helping portfolio companies enhance their growth potential and navigate cross-border technology markets.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.